Erdafitinib in BCG-treated high-risk non-muscle-invasive bladder cancer
Titel:
Erdafitinib in BCG-treated high-risk non-muscle-invasive bladder cancer
Auteur:
Catto, J.W.F. Tran, B. RouprĂȘt, M. Gschwend, J.E. Loriot, Y. Nishiyama, H. Redorta, J.P. Daneshmand, S. Hussain, S.A. Cutuli, H.J. Procopio, G. Guadalupi, V. Vasdev, N. Naini, V. Crow, L. Triantos, S. Baig, M. Steinberg, G.